The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|899-1987|10|1172-1180

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.899-1987, Iss.10, 2015-10, pp. : 1172-1180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers

By  

Molecular Carcinogenesis, Vol. 54, Iss. 10, 2015-10 ,pp. : 1172-1180

John Wiley & Sons Inc

Access to resources Recommend Favorite

DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor‐alpha/breast cancer susceptibility gene 1 and poor prognosis

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 707-719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non‐small cell lung cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E52-E60

John Wiley & Sons Inc

Access to resources Recommend Favorite

LncAPC drives Wnt/β‐catenin activation and liver TIC self‐renewal through EZH2 mediated APC transcriptional inhibition

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 408-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

PPARγ‐inactive Δ2‐troglitazone independently triggers ER stress and apoptosis in breast cancer cells

By  

Molecular Carcinogenesis, Vol. 54, Iss. 5, 2015-05 ,pp. : 393-404

John Wiley & Sons Inc

Access to resources Recommend Favorite